Notes / Company

Supriya Lifescience Ltd.

SUPRIYA BSE 543434 ISIN INE07RO01027 CDMO

Fundamentals

Market cap: ₹7,470 cr
P/E: 35.72×
ROE: 18.86%
Debt / equity: 0.00
Div yield: 0.10%
52-week range: 545.50 — 1085.00

Research on Tijori Finance

Company snapshot

Supriya Lifescience Ltd.

CDMO

₹7,884 cr

P/E 37.70×

Latest quarter · Mar 2026

Sales₹277 cr

Net profit₹74 cr

Op. margin+35.3%

EPS₹9.22

Strength & growth

Debt / equity0.00×

Current ratio5.07×

The timeline — 2 notes on Supriya Lifescience Ltd.

July 2026

04 Jul 26 · 5:26 AM IST Brief

Brief · Regulatory · Mid cap

Supriya Lifescience GM in judicial custody for NDPS export lapse

Company says no material impact on operations, citing isolated procedural lapse in a single export transaction.

June 2026

02 Jun 26 · 4:14 PM IST Brief

Brief · Earnings · Mid cap

Supriya Lifescience posts 50% revenue jump, clears USFDA inspection

Quarterly revenue hit ₹277 crore, net profit rose 47% to ₹74 crore. The Lote facility received a VAI classification from the USFDA.

Verify on exchange BSE filings for SUPRIYA NSE filings for SUPRIYA Tijori Finance company page